What percentage of deceased kidney donors and kidney transplant recipients develop disseminated intravascular coagulation (DIC)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

DIC Incidence in Kidney Transplantation

Disseminated intravascular coagulation (DIC) occurs in approximately 24-50% of deceased kidney donors with traumatic brain death, but is extremely rare in kidney transplant recipients themselves.

DIC in Deceased Kidney Donors

Incidence in Donors with Head Injury

  • Post-head injury DIC affects 24-50% of brain-dead deceased donors, making it a relatively common finding in the donor population 1
  • The incidence is specifically associated with traumatic brain injury leading to brain death, which is a major source of organs for transplantation 1

Clinical Context

  • DIC in donors has historically been considered a relative contraindication to organ donation due to concerns about primary graft non-function 1
  • However, recent evidence demonstrates that donor DIC does not significantly impact recipient outcomes when donors are carefully selected 2

DIC in Kidney Transplant Recipients

Transient DIC Transmission

  • Recipients can develop transient, low-grade DIC that typically resolves within 5-7 days post-transplant when receiving kidneys from DIC-positive donors 3
  • Thrombocytopenia occurs more frequently in recipients of DIC-positive donor kidneys (statistically significant association, P=0.008) 4

Clinical Outcomes

  • Despite donor DIC, delayed graft function occurs in approximately 28.1% of recipients from DIC-positive donors versus 22.8% from DIC-negative donors (not statistically significant) 2
  • Long-term graft survival at 1,5, and 10 years shows no significant difference: 94.5%, 89.3%, and 73.9% for DIC-positive donors versus 96.2%, 90.8%, and 81.3% for DIC-negative donors 2

Key Clinical Implications

Donor Selection Criteria

  • Donor DIC alone should not be an absolute contraindication to kidney donation when other risk factors for primary non-function are excluded 1
  • Even donors with severe DIC, deranged renal function, and 100% glomerular fibrin thrombi on biopsy have resulted in successful transplants with stable long-term function 5

Recipient Monitoring

  • Thrombocytopenia in recipients of DIC-positive kidneys is independently associated with delayed/slow graft function (P=0.005) and should trigger close monitoring 4
  • Recipients may require temporary hemodialysis support (ranging from 18-39 days post-transplant in severe cases) before achieving stable graft function 5

Long-term Prognosis

  • Patient and graft survival at 1 year are not affected by donor DIC status or recipient thrombocytopenia 4
  • Median estimated glomerular filtration rate remains similar between recipients of DIC-positive and DIC-negative donors at 3 months, 1 year, and 10 years post-transplant 2

References

Research

No impact of disseminated intravascular coagulation in kidney donors on long-term kidney transplantation outcome: A multicenter propensity-matched study.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2019

Research

Disseminated intravascular coagulation (DIC) in a kidney donor associated with transient recipient DIC.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2005

Research

Implications of donor disseminated intravascular coagulation on kidney allograft recipients.

Clinical journal of the American Society of Nephrology : CJASN, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.